Reinhard Karl Kage, MD | |
361 Main St, Manchester, CT 06040-4127 | |
(860) 646-9929 | |
(860) 646-7999 |
Full Name | Reinhard Karl Kage |
---|---|
Gender | Male |
Speciality | Allergy & Immunology |
Location | 361 Main St, Manchester, Connecticut |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1902891013 | NPI | - | NPPES |
2622766 | Other | AETNA PROVIDER ID | |
0V9772 | Other | HEALTH NET PROVIDER ID | |
010033888CT01 | Other | ANTHEM PROVIDER ID |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207K00000X | Allergy & Immunology | 039413 (Connecticut) | Primary |
Mailing Address | Practice Location Address |
---|---|
Reinhard Karl Kage, MD 361 Main St, Manchester, CT 06040-4127 Ph: (860) 646-9929 | Reinhard Karl Kage, MD 361 Main St, Manchester, CT 06040-4127 Ph: (860) 646-9929 |
News Archive
What starts as burning, numbness, pain, and/or tingling in the feet, or hands in some can turn into a debilitating condition. Peripheral Neuropathy (PN), one of the largest and most common neurodegenerative disorders, affects more than 20 million Americans of all races and ethnic backgrounds.
ACCESS PHARMACEUTICALS, INC. today provided an update on its European commercial launch of MuGard, an FDA approved treatment for oral mucositis, a debilitating side effect of radiation treatment and chemotherapy.
Smiths Medical, a leading global medical device manufacturer, announced today it received a license from Health Canada and launched its Medfusion® 4000 syringe infusion pump with the PharmGuard® software suite in Canada. The new customizable system allows health care providers to send and receive medication delivery information more efficiently, helping to prevent medication errors.
The severe neurodegeneration associated with Huntington's disease may result from molecular mutations that block the transport of nutrients within cells.
› Verified 8 days ago